tiprankstipranks
Advertisement
Advertisement

GB:VAL Stock Latest News

ValiRx Raises £1.16m in Oversubscribed Retail and Placing Fundraise
Company AnnouncementsValiRx Raises £1.16m in Oversubscribed Retail and Placing Fundraise
17h ago
ValiRx Extends £1.15m Fundraise with UK Retail Share Offer and Attached Warrants
PremiumCompany Announcements
ValiRx Extends £1.15m Fundraise with UK Retail Share Offer and Attached Warrants
4d ago
ValiRx launches discounted £1.155m raise to fund IP expansion and animal health push
PremiumCompany Announcements
ValiRx launches discounted £1.155m raise to fund IP expansion and animal health push
7d ago
ValiRx updates registered office as it advances oncology and women’s health focus
PremiumCompany Announcements
ValiRx updates registered office as it advances oncology and women’s health focus
2M ago
ValiRx trims costs and expands oncology pipeline with new human and veterinary initiatives
PremiumCompany Announcements
ValiRx trims costs and expands oncology pipeline with new human and veterinary initiatives
2M ago
ValiRx gains oncology spotlight with digital twin data and expanding scientific footprint
PremiumCompany AnnouncementsValiRx gains oncology spotlight with digital twin data and expanding scientific footprint
2M ago
ValiRx CEO Increases Stake with 1 Million-Share Purchase
Premium
Company Announcements
ValiRx CEO Increases Stake with 1 Million-Share Purchase
3M ago
ValiRx launches veterinary oncology arm to tap fast-growing animal cancer market
Premium
Company Announcements
ValiRx launches veterinary oncology arm to tap fast-growing animal cancer market
3M ago
ValiRx Issues 80,000 New Shares Following Warrant Exercise
PremiumCompany Announcements
ValiRx Issues 80,000 New Shares Following Warrant Exercise
4M ago
ValiRx Strikes RNA Helicase Deal with McGill and IRICoR Under Asset-Focused Funding Model
PremiumCompany Announcements
ValiRx Strikes RNA Helicase Deal with McGill and IRICoR Under Asset-Focused Funding Model
4M ago
ValiRx Strikes RNA Helicase Inhibitor Deal with McGill and IRICoR to Drive Asset-Level Growth
PremiumCompany Announcements
ValiRx Strikes RNA Helicase Inhibitor Deal with McGill and IRICoR to Drive Asset-Level Growth
4M ago
ValiRx Advances with New Equity and Warrant Issuance Post-General Meeting
PremiumCompany Announcements
ValiRx Advances with New Equity and Warrant Issuance Post-General Meeting
6M ago
ValiRx PLC Announces Fundraising to Boost Cancer and Women’s Health Research
PremiumCompany AnnouncementsValiRx PLC Announces Fundraising to Boost Cancer and Women’s Health Research
7M ago
ValiRx PLC Raises £902,000 Through Successful Fundraising
Premium
Company Announcements
ValiRx PLC Raises £902,000 Through Successful Fundraising
7M ago
ValiRx Plc Raises £902,000 Through Successful WRAP Retail Offer
Premium
Company Announcements
ValiRx Plc Raises £902,000 Through Successful WRAP Retail Offer
7M ago
ValiRx Plc Launches £300,000 Retail Offer to Boost Cancer Therapeutics Development
PremiumCompany Announcements
ValiRx Plc Launches £300,000 Retail Offer to Boost Cancer Therapeutics Development
7M ago
ValiRx PLC Launches £1.05 Million Fundraising to Boost Cancer and Women’s Health Initiatives
PremiumCompany Announcements
ValiRx PLC Launches £1.05 Million Fundraising to Boost Cancer and Women’s Health Initiatives
7M ago
ValiRx PLC Advances Cancer Therapeutics with Strategic Partnerships and Innovations
PremiumCompany Announcements
ValiRx PLC Advances Cancer Therapeutics with Strategic Partnerships and Innovations
7M ago
ValiRx Reports Strategic Advancements and Cost Efficiency in H1 2025
PremiumCompany Announcements
ValiRx Reports Strategic Advancements and Cost Efficiency in H1 2025
8M ago
ValiRx Advances Cancer Therapeutics with Digital Twin Collaboration
PremiumCompany AnnouncementsValiRx Advances Cancer Therapeutics with Digital Twin Collaboration
8M ago
ValiRx’s Cytolytix Advances Cancer Therapeutics with Key Patent and Platform Developments
Premium
Company Announcements
ValiRx’s Cytolytix Advances Cancer Therapeutics with Key Patent and Platform Developments
9M ago
ValiRx Expands Prostate Cancer Portfolio with New Subsidiary
Premium
Company Announcements
ValiRx Expands Prostate Cancer Portfolio with New Subsidiary
9M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >